Journal
JOURNAL OF FELINE MEDICINE AND SURGERY
Volume 24, Issue 10, Pages 943-953Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1098612X211048647
Keywords
Feline infectious peritonitis; FIPV; coronavirus; antiviral; combined anti-coronaviral therapy
Categories
Funding
- EveryCat Health Foundation [W17-020, W19-026, W20-003]
- University of California, Davis Center for Companion Animal Health (CCAH)
- Philip Raskin Fund, Kansas City, KS, USA
Ask authors/readers for more resources
This study identified 26 compounds with effective antiviral activity against FIPV through in vitro screening, including a variety of drug classes and mechanisms of antiviral action. The most effective compounds were GC376, GS-441524, EIDD2081, and EIDD2931. Combinations of antiviral agents also showed some evidence of limited synergistic antiviral activity.
Objectives Feline infectious peritonitis (FIP), caused by genetic mutants of feline enteric coronavirus known as FIPV, is a highly fatal disease of cats with no currently available vaccine or US Food and Drug Administration-approved cure. Dissemination of FIPV in affected cats results in a range of clinical signs, including cavitary effusions, anorexia, fever and lesions of pyogranulomatous vasculitis and perivasculitis, with or without central nervous system or ocular involvement. The objectives of this study were to screen an array of antiviral compounds for anti-FIPV (serotype II) activity, determine cytotoxicity safety profiles of identified compounds with anti-FIPV activity and strategically combine identified monotherapies to assess compound synergy against FIPV in vitro. Based upon clinically successful combination treatment strategies for human patients with HIV and hepatitis C virus infections, we hypothesized that a combined anticoronaviral therapy approach featuring concurrent multiple mechanisms of drug action would result in an additive or synergistic antiviral effect. Methods This study screened 90 putative antiviral compounds for efficacy and cytotoxicity using a multimodal in vitro strategy, including plaque bioassays, real-time RT-PCR viral inhibition and cytotoxicity assays. Results Through this process, we identified 26 compounds with effective antiviral activity against FIPV, representing a variety of drug classes and mechanisms of antiviral action. The most effective compounds include GC376, GS-441524, EIDD2081 and EIDD2931. We documented antiviral efficacy for combinations of antiviral agents, with a few examined drug combinations demonstrating evidence of limited synergistic antiviral activity. Conclusions and relevance Although evidence of compound synergy was identified for several combinations of antiviral agents, monotherapies were ultimately determined to be the most effective in the inhibition of viral transcription.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available